Luminostics Inc.
- UEI
- UKDFFURQW5Z1
- CAGE
- 74HS9
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Covid-19 rapid antigen test kits product expansion effort | AFLCMC Hill AFB | $2,000,000 | |
| Radx-tech - luminostics, INC. Smartphone-based point-of-care test for rapid sars-COV-2 antigen detection from nasal… | National Heart Lung and Blood Institute | $39,067,500 | |
| A smartphone-based rapid point-of-care test for sars-COV-2 detection from respiratory samples | National Institute of Allergy and Infectious Diseases | $964,604 | |
| Purpose: contract award for sbir topic 073 phase i "a smartphone-based point-of-care test for detection of influenza… | National Institute of Allergy and Infectious Diseases | $200,000 | |
| A smartphone-based point-of-care test for detection of chlamydia trachomatis | National Institutes of Health | $218,522 |
About Luminostics Inc.
Luminostics Inc. is a for-profit corporate entity that provides medical testing products and services to the U.S. federal government. Specifically, it develops and delivers rapid COVID-19 and influenza testing kits and related smartphone-based diagnostic platforms.
Through past prime federal contract awards, Luminostics has provided COVID-19 rapid antigen test kits to the Department of Defense to support coronavirus testing requirements. It also delivered a smartphone-based point-of-care testing platform and SARS-CoV-2 antigen detection kits to the National Institutes of Health to enable rapid on-site COVID-19 screening without specialized equipment.
Through a prime federal grant award from the National Institute of Allergy and Infectious Diseases, Luminostics developed a smartphone-based rapid point-of-care test for detecting SARS-CoV-2 from respiratory samples. As a subawardee on a grant from Emory University, Luminostics contributed to a project focused on engineered point-of-care testing technologies.
Quick answers
What is Luminostics Inc.'s UEI?
Luminostics Inc.'s Unique Entity ID (UEI) in SAM.gov is UKDFFURQW5Z1.
What is Luminostics Inc.'s CAGE code?
Luminostics Inc.'s CAGE code is 74HS9.
What is Luminostics Inc.'s primary NAICS code?
Luminostics Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Is Luminostics Inc. registered in SAM.gov?
Luminostics Inc.'s SAM.gov registration expired on May 26, 2023.
What is Luminostics Inc.'s most recent federal award?
Luminostics Inc.'s most recent federal contract award is Covid-19 rapid antigen test kits product expansion effort (FA821021C0001), from AFLCMC Hill AFB, on August 30, 2021.
On GovTribe
See Luminostics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors